Aims: Asthma is an inflammatory lung disease characterized by bronchoconstriction and hyper responsiveness. Immuno stimulatory effects of melatonin have been reported. In this study, we investigated the impact of melatonin administration on allergic airway inflammation in a rat model. Methods: Forty five adult Wistar albino rats were equally divided into three groups: group I served as control; group II: rats sensitized to ovalbumin and challenged intranasally with ovalbumin to induce an allergic inflammatory response and group III, rats were sensitized and treated with intraperitoneally melatonin. The serum levels of IgE, IgG1 and ova-specific IgG were measured by ELISA. In the bronchoalveolar lavage fluid (BALF), the levels of IL-4, IL-5, IL-13, 1L-10 were measured. IL-10 expression was measured by real time polymerase chain reaction. Histopathological examination of the lung tissues using H&E stain were done. Results:
INTRODUCTION
Therefore, many studies are being designed to develop novel, and safer therapies for asthma (5,6).
Melatonin has been shown to enhance the cytokines production, and has a modulatory role in lymphocyte proliferation (7) . The biological activities of melatonin and its effect on inflammatory cells have been reported (8) .
Melatonin appears to have an important immunomodulatory effect in allergic diseases (9) .
In addition, Shaji and colleagues (10) demonstrated that melatonin enhanced the proliferation of ovalbumin-specific CD4-positive T lymphocytes.
Considering the importance of the inflammatory response in the development of asthma, the hypothesis of this study was to investigate the impact of melatonin administration on inflammatory responses associated with the asthmatic airway in adult male rat model.
MATERIALS AND METHODS

Experimental Design:
The experimental protocol was approved by the Group I: the rats were sham sensitized and exposed to phosphate buffered saline (PBS), served as control.
Group II: the rats were sensitized and challenged with ovalbumin (OVA) (Sigma Chemical Co.,
USA),
Group III: the rats were sensitized and challenged with OVA and the rats in this group received a daily intra peritoneal (i.p.) injection of melatonin 5 mg/Kg.
Group IV: the rats were injected with melatonin (5 mg/kg. i.p.) daily from the first day until the last day of the experiment.
Sensitization/Treatment protocol:
Induction of allergic airway inflammation was performed by intra peritoneal (i.p.) sensitization and airway challenge through nasal inhalation.
Groups II and III were sensitized on day 0 by intra peritoneal injection of 10 µg of OVA per animal 
Estimation of BALF cytokines and serum levels of cortisol:
The levels of IL-4, IL-5, and IL-10 of BALF were analyzed using ELISA kits (R &D Systems, Minneapolis, USA) as previously described (13) .
Serum cortisol levels were measured by radioimmunoassay (14) .
Determination of OVA-specific IgG1:
The serum level of OVA-specific IgG1 was measured by ELISA. Briefly, the 96-well roundbottom micro titer plates were coated for overnight at 4 o C with 100 ml of 100 mg/ml OVA in 
Total serum IgE and IgG1 levels:
The 96-well round-bottom microtiter plates were coated overnight at 4 0C with mouse anti-rat 5\ATTTGGCGTGAGTGGAGTCAT-3/. The expression level was calculated using the ∆∆ Ct (the comparative threshold cycle) method relative to the production of GAPDH (2).
Histopathological examination:
Lung specimens were fixed immediately in 10% buffered formalin, embedded in paraffin, prepared as 4-μm-thick sections and stained with hematoxylin and eosin (HE). Stained sections were examined under light microscope (Olympus CX31, Japan) and photographed using digital camera (Olympus, Camedia C-5060, Japan) (15).
Statistical Analysis:
Data were expressed as mean ± standard 
RESULTS
Effects of melatonin administration on serum levels of total IgE, IgG1and OVA-specific IgG1 levels:
The serum levels of total IgE, IgG1 and OVAspecific IgG1 of group II were significantly elevated compared to group I and IV (p<0.001).However, melatonin administration decreased these elevated levels in the serum of group III compared to control rats and group IV (p<0.05) ( Fig.1) .
Effects of melatonin administration on inflammatory cells count in BALF:
To examine the effect of melatonin administration on lung inflammation in OVA sensitized rats, total and differential cell numbers in the BAL fluid were counted. Total serum IgE, IgG1 and OVA-specific IgG1 in all studied groups (A) Levels of total serum IgE of rats in the four studied groups. Significant increased total Serum IgE in rats of group II as compared to control rats and group IV. Melatonin significantly (P < 0.01) reduced the elevated treated rats of group III. (B) Total serum IgG1 levels increased significantly in OVA sensitized rats of group II as compared to group I and IV (P<0.001). Melatonin significantly lowered the level of total serum IgG1 in rats of group III compared to group I (P<0.01) (C) OVA-specific IgG1 measured in the four groups. Melatonin significantly (P < 0.001) reduced the raised level of OVA-specific IgG1 in rats of group II. All data are represented as mean ± SD for 15 rats each group. Significant levels are ***P <0.001,**P < 0.01 and *P< 0.05 comparing two groups. The results presented in Table 1 showed that OVA Table 2) .
Effects of melatonin administration on the serum cortisol levels: Table 1 showed that serum cortisol levels, assessed in all studied groups, indicated that neither the antigen challenge, nor melatonin treatment groups influenced serum cortisol levels when compared with that obtained from the control group.
Effects of melatonin administration on IL-10 mRNA expression:
Sensitization with OVA resulted in a significant decrease in IL-10 mRNA expression levels compared to control group. Interestingly, administration of melatonin to OVA-sensitized rats completely reversed the decrease in IL-10 mRNA expression to the control values (Fig.3) . Data are presented as mean ± SD (15 rats in each group).a: significant as compared with group I , P < 0.05.b: significant as compared to group II, P < 0.05.c: significant as compared to group III, P < 0.05.NS: non-significant as compared to group I.
The IL-10 mRNA expression levels of group IV did not differ significantly than those of group I.
Histopathological results:
Histopathological examination of lung control rats and rats of group IV showed normal appearance (Fig.4a) . Lung sections of OVA treated rats revealed pathological changes (Fig. 4b) . These changes were consisted of hyperplasia of the pneumocyte type II (Fig.5a ), pulmonary eosinophilic infiltrations especially around the blood vessels (Fig. 5b) , hyperplasia of the goblet cells (Fig. 5c) , and numerous lymphocytes and macrophages laden with hemosiderin pigment (Fig. 5d) . Rats of group III revealed inhibition of the infiltration of inflammatory cells, no hyperplasia of the pneumocyte type II and goblet cells (Fig. 4c) .
Fig. 4 (a-c):
Representative micrograph of the lung from group I,II and III respectively. H&E stain. Bar= 100µm. 
